COMMUNIQUÉS West-GlobeNewswire

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
18/09/2025
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
18/09/2025
CONSHOHOCKEN, Pa., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
Palisade Bio Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
18/09/2025
Carlsbad, CA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company advancing novel therapeutics for patients [...]
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/09/2025
FOSTER CITY, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted equity awards covering an aggregate of 966,000 [...]
iCare ABA Therapy Launches With AI-Supported Model, Sparks Industry Debate on AI’s Role in Autism Care
18/09/2025
New York, NY, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The soft launch of iCare ABA Therapy is drawing attention across healthcare, real estate, and investment circles for one reason: its deliberate investment in artificial [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
18/09/2025
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on September 15, 2025 it granted stock options to purchase an aggregate of 39,790 shares of [...]
Compass Health Celebrates Grand Opening of Marc Healing Center
18/09/2025
At ribbon-cutting ceremony, regional leaders mark completion of state-of-the-art facility designed to address Northwest Washington’s most complex behavioral health needs EVERETT, Wash., Sept. 18, 2025 (GLOBE NEWSWIRE [...]
Immix Biopharma Announces 50% Enrollment Milestone Surpassed in its ongoing relapsed/refractory AL Amyloidosis Clinical Trial, NEXICART-2
18/09/2025
– On track for first FDA Biologics License Application (BLA) approved cell therapy in orphan indication relapsed/refractory AL Amyloidosis – Los Angeles, CA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ [...]
Toni Pashley joins Scene Health as Chief Product Officer to help solve the Medication Adherence challenge
18/09/2025
BALTIMORE, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Scene Health, a leader in MedEngagement, welcomes Toni Pashley as its new Chief Product Officer (CPO), marking a transformative moment for Scene as they accelerate their [...]
Kuros statement on media inquiry concerning former Board member
18/09/2025
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros statement on media inquiry concerning former Board member Schlieren (Zurich), Switzerland, September 18, 2025 – Kuros Biosciences (“Kuros” or the [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2025
18/09/2025
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2025 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les [...]
OrganOx metra® Receives FDA Approval for Operation During Air Transport, Expanding Access to Life-Saving Liver Perfusion Technology
18/09/2025
Partnership with Strata Critical Medical (NASDAQ:SRTA) enables 24/7, device-to-donor support across the U.S. OrganOx Ltd., the organ technology company tackling the world's toughest transplant challenges, announced that [...]
Dark Horse Consulting Group Acquires Converge Consulting
18/09/2025
WALNUT CREEK, Calif. and CAMBRIDGE, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group (“DHCG” or “the Group”), a leader in strategic and operational consulting in advanced therapies—specifically the [...]
After Transforming Neuro Care, Sevaro Secures $39M to Expand AI-Powered Specialty Care Platform
18/09/2025
NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Sevaro Health, the company transforming neurological care in the United States, today announced the close of a $39 million oversubscribed Series B funding round . The round [...]
Senti Bio to Present at the MedInvest Biotech & Pharma Conference
18/09/2025
Live webcast presentation on Wednesday, September 24th at 9:55 AM PT SOUTH SAN FRANCISCO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology [...]
HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing
18/09/2025
Wugen closed a $115 million equity financing led by Fidelity Management & Research Company HCW Biologics holds a minority equity interest in Wugen MIRAMAR, Fla., Sept. 18, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc [...]
BioCardia Announces Pricing of Up To $12 Million Public Offering
18/09/2025
$6 million upfront with up to an additional $6 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [ [...]
Replimune Provides Update Following Type A Meeting with FDA
18/09/2025
WOBURN, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the [...]
First Insight Launches MaximEyes AI, Powered by EVAA
18/09/2025
New AI suite automates front- and back-office workflows, giving eye care practices more time for patients PORTLAND, Ore., Sept. 18, 2025 (GLOBE NEWSWIRE) -- First Insight, a leader in eye care EHR and practice [...]

Pages